32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis.

      Nature medicine
      Adhesins, Escherichia coli, immunology, Amino Acid Sequence, Animals, Antibodies, Antineutrophil Cytoplasmic, analysis, Autoantibodies, blood, Enzyme-Linked Immunosorbent Assay, Epitopes, Fimbriae Proteins, Glomerulonephritis, etiology, Gram-Negative Bacterial Infections, Humans, Immunization, Immunoglobulin G, Lysosomal-Associated Membrane Protein 2, Lysosome-Associated Membrane Glycoproteins, chemistry, Molecular Sequence Data, Necrosis, Neutrophil Activation, Rats, Rats, Inbred WKY

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pauci-immune focal necrotizing glomerulonephritis (FNGN) is a severe inflammatory disease associated with autoantibodies to neutrophil cytoplasmic antigens (ANCA). Here we characterize autoantibodies to lysosomal membrane protein-2 (LAMP-2) and show that they are a new ANCA subtype present in almost all individuals with FNGN. Consequently, its prevalence is nearly twice that of the classical ANCAs that recognize myeloperoxidase or proteinase-3. Furthermore, antibodies to LAMP-2 cause pauci-immune FNGN when injected into rats, and a monoclonal antibody to human LAMP-2 (H4B4) induces apoptosis of human microvascular endothelium in vitro. The autoantibodies in individuals with pauci-immune FNGN commonly recognize a human LAMP-2 epitope (designated P(41-49)) with 100% homology to the bacterial adhesin FimH, with which they cross-react. Rats immunized with FimH develop pauci-immune FNGN and also develop antibodies to rat and human LAMP-2. Finally, we show that infections with fimbriated pathogens are common before the onset of FNGN. Thus, FimH-triggered autoimmunity to LAMP-2 provides a previously undescribed clinically relevant molecular mechanism for the development of pauci-immune FNGN.

          Related collections

          Author and article information

          Comments

          Comment on this article